Trials / Completed
CompletedNCT00970047
Development of a Fetal Sex Assay From Maternal Whole Blood
Development of a Noninvasive Fetal Sex Determination Test Between 6 and 16 Weeks of Gestation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Sequenom, Inc. · Industry
- Sex
- Female
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
Whole blood from pregnant women will be collected to develop a noninvasive fetal sex test.
Detailed description
This is an observational study whereby samples will be tested to determine the presence or absence of fetal Y chromosome genes to test for the fetal sex of the baby. The blood draw will occur between 6 to 16 weeks of gestation. The fetal gender will be requested at or soon after delivery if fetal sex was not previously obtained by CVS or amniocentesis genetic analysis.
Conditions
Timeline
- Start date
- 2008-06-01
- Primary completion
- 2010-07-01
- Completion
- 2010-07-01
- First posted
- 2009-09-02
- Last updated
- 2011-02-02
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00970047. Inclusion in this directory is not an endorsement.